From June 9, 2022 to June 22, 2023, the company has repurchased 634,881 shares, representing 0.4% for AUD 1.28 million. With this, the company has completed the repurchase of 634,881 shares, representing 0.4% for AUD 1.28 million under the buyback announced on June 9, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 AUD | -2.42% | +27.78% | +91.67% |
03-26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
03-18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+91.67% | 182M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.58% | 21.25B | |
-5.52% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- RAC Stock
- News Race Oncology Limited
- Tranche Update on Race Oncology Limited's Equity Buyback Plan announced on June 9, 2022.